Clarivate (NYSE:CLVT – Get Free Report) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 0.700-0.800 for the period, compared to the consensus estimate of 0.740. The company issued revenue guidance of $2.6 billion-$2.7 billion, compared to the consensus revenue estimate of $2.6 billion. Clarivate also updated its FY24 guidance to $0.70 to $0.80 EPS.
Clarivate Price Performance
Clarivate stock remained flat at $5.69 during mid-day trading on Friday. The company’s stock had a trading volume of 8,002,078 shares, compared to its average volume of 4,404,263. The company has a 50 day moving average price of $5.88 and a 200 day moving average price of $6.94. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.86 and a current ratio of 0.86. The firm has a market cap of $3.80 billion, a P/E ratio of -3.42, a PEG ratio of 4.38 and a beta of 1.15. Clarivate has a 52-week low of $4.97 and a 52-week high of $9.60.
Clarivate (NYSE:CLVT – Get Free Report) last announced its earnings results on Tuesday, August 6th. The company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.02. Clarivate had a positive return on equity of 10.11% and a negative net margin of 39.29%. The firm had revenue of $650.30 million for the quarter, compared to the consensus estimate of $651.94 million. During the same quarter in the previous year, the business earned $0.16 EPS. The firm’s revenue for the quarter was down 2.8% on a year-over-year basis. On average, analysts expect that Clarivate will post 0.62 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Read Our Latest Report on CLVT
Clarivate Company Profile
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Featured Articles
- Five stocks we like better than Clarivate
- Consumer Discretionary Stocks Explained
- The Cannabis Sector: Profitability Takes Center Stage
- Short Selling: How to Short a Stock
- Amazon’s Stock Plunge: Is a Prime Buying Opportunity Knocking?
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Buy the Dip in e.l.f. Beauty: Analysts Point to a New High
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.